药品集中采购中相关法律问题的思考

发布时间：2018-01-22 02:51

本文关键词： 药品采购集中采购法律问题招投标法政府采购法　出处：《中国药房》2017年18期 　论文类型：期刊论文

【摘要】：目的:从法律层面为完善我国药品集中采购政策提供建议。方法:梳理我国的药品集中采购政策,并与相应的法律法规进行对照,分析存在的问题,提出完善建议。结果:我国现行的药品集中采购政策主要与《招投标法》《政府采购法》《反垄断法》和《反不正当竞争法》有关条款存在冲突。在药品集中采购机构设置方面与《招投标法》和《政府采购法》有冲突;在量价挂钩、招标主体等方面与《招投标法》有冲突;组织机构和参与方的某些做法与《反垄断法》和《反不正当竞争法》存在冲突。结论:我国药品集中招标采购制度应理顺招标主体,实施带量采购、量价挂钩,通过推进配套的医药卫生改革建立合理的激励机制,建立健全药品监管领域现代施政原则,使得药品集中采购制度能更好地与相关法律相适应,以此提高采购效率。
[Abstract]:Objective: to provide suggestions for the improvement of the centralized drug procurement policy in China from the legal level. Methods: to sort out the centralized drug procurement policy in China, and compare it with the corresponding laws and regulations, and analyze the existing problems. Suggestions for improvement. Results:. The current centralized purchasing policy of drugs in China is mainly in conflict with the relevant provisions of the Law on bidding, the Law on Government Procurement, the Law on Anti-monopoly and the Law on Anti-unfair Competition. There is a conflict between the Law on tenders and the Law on Government Procurement; There is a conflict between the quantity and price, the subject of bidding and the Law of bidding; Some practices of organizations and participants are in conflict with Anti-monopoly Law and Anti-unfair Competition Law. Conclusion: the centralized bidding system of drugs in China should rationalize the main body of bidding, carry out the purchase with quantity and price. Through the promotion of supporting medical and health reform to establish a reasonable incentive mechanism, establish and improve the field of modern drug administration principles, so that centralized drug procurement system can better adapt to the relevant laws. In order to improve the efficiency of procurement.
【作者单位】：中国医学科学院/北京协和医学院公共卫生学院;
【基金】：中央级公益性科研院所基本项目国家卫生计生委药政司委托研究课题(No.药政[2016]9号)
【分类号】：D922.2;R95
【正文快照】： 通过省级药品集中采购平台进行的药品集中采购制度是我国医药卫生体制改革的重要配套政策之一,也是深化医药卫生体制改革的关键环节之一,旨在通过实施政府主导、以省(区、市)为单位的网上药品集中采购模式达到“降低药品虚高价格、预防和遏制腐败行为、整合重组药品生产流通企

【相似文献】